Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Opiant Pharmaceuticals, Inc. (OPNT)

11.95   -0.04 (-0.33%) 07-02 16:00
Open: 11.97 Pre. Close: 11.99
High: 12.4889 Low: 11.5
Volume: 11,104 Market Cap: 61(M)
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.49 - 12.58 12.58 - 12.65
Low: 11.35 - 11.43 11.43 - 11.49
Close: 11.83 - 11.96 11.96 - 12.07

Technical analysis

as of: 2022-07-01 4:24:12 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 15.5     One year: 17.5
Support: Support1: 10.48    Support2: 8.72
Resistance: Resistance1: 13.27    Resistance2: 14.98
Pivot: 11.57
Moving Average: MA(5): 11.95     MA(20): 11.74
MA(100): 19.31     MA(250): 22.16
MACD: MACD(12,26): -0.7     Signal(9): -1
Stochastic oscillator: %K(14,3): 57.2     %D(3): 56.8
RSI: RSI(14): 44.5
52-week: High: 37.7  Low: 7.34
Average Vol(K): 3-Month: 90 (K)  10-Days: 22 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ OPNT ] has closed below upper band by 33.7%. Bollinger Bands are 63.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 28 Jun 2022
2022-06-28 | NDAQ:OPNT | Press Release | Opiant Pharmaceuticals Inc. - Stockhouse

Mon, 13 Jun 2022
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Director Craig A. Collard Acquires 1663 Shares - Defense World

Thu, 09 Jun 2022
Health Care Sector Update for 06/09/2022: SONN, OPNT, CVAC, XLV, IBB - Nasdaq

Wed, 08 Jun 2022
Opiant Pharmaceuticals and Aptar Pharma Expand Long-Term Collaboration for the Manufacture of Unidose Nasal Spray for OPNT003, Nasal Nalmefene - Yahoo Finance

Wed, 08 Jun 2022
Michael Sinclair Sells 7688 Shares of Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Stock - Defense World

Mon, 06 Jun 2022
Small Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER) - BP Journal

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 5 (M)
Shares Float 5 (M)
% Held by Insiders 6.8 (%)
% Held by Institutions 34 (%)
Shares Short 66 (K)
Shares Short P.Month 29 (K)

Stock Financials

EPS 0.31
EPS Est Next Qtl 0
EPS Est This Year 0.5
EPS Est Next Year 1.25
Book Value (p.s.) 9.1
Profit Margin (%) 6.3
Operating Margin (%) 10.7
Return on Assets (ttm) 4.9
Return on Equity (ttm) 7.3
Qtrly Rev. Growth 39
Gross Profit (p.s.) 4.63
Sales Per Share 10.12
EBITDA (p.s.) 1.11
Qtrly Earnings Growth 0
Operating Cash Flow 2 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 38.54
PEG Ratio 0
Price to Book value 1.31
Price to Sales 1.18
Price to Cash Flow 29.22

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.